Description
Tenet Healthcare: USPI Resiliency & Growth Driving Our ‘Buy’ Rating!
Tenet Healthcare’s performance for the fourth quarter of 2024 and the full year was marked by significant operational achievements and strategic transactions aimed at strengthening its financial posture and business flexibility. The company reported net operating revenues of $20.7 billion with a consolidated adjusted EBITDA of $4 billion for the year, reflecting a 13% increase over 2023 and an enhanced EBITDA margin of 19.3%. This performance was buoyed by robust same-store revenue growth across its segments and disciplined cost management.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
